Aehr Test Systems - Common Stock (AEHR)
Healthcare › Instruments For Meas & Testing of Electricity & Elec Signals
Price History
Feb 9, 2026 — May 24, 2026Investment Snapshot
- P/B of 21.53 — trading above book value
- Piotroski F-Score 2/9 — signs of financial weakness
- Loss-making — negative ROE of -6.6%
- Revenue declining 11% annually
Aehr Test Systems - Common Stock (AEHR) is a Healthcare company operating in Instruments For Meas & Testing of Electricity & Elec Signals, listed on the NASDAQ , with a market capitalisation of $3.0 billion . Key value metrics: P/B ratio 21.53, Piotroski F-Score 2 out of 9 .
Value Score
Key Metrics
Current vs 5-Year Average
Based on 5 years of SEC filingsRevenue & Net Income
Financial Statements
| Metric | FY22 | FY23 | FY24 |
|---|---|---|---|
| Revenue | $X.XB | $X.XB | $X.XB |
| Gross Profit | $X.XB | $X.XB | $X.XB |
| Operating Income | $X.XB | $X.XB | $X.XB |
| Net Income | $X.XB | $X.XB | $X.XB |
| EBITDA | $X.XB | $X.XB | $X.XB |
| Total Assets | $X.XB | $X.XB | $X.XB |
| Total Liabilities | $X.XB | $X.XB | $X.XB |
Aehr Test Systems - Common Stock — Fundamental Analysis Summary
On financial health, AEHR shows a weak Piotroski F-Score of 2/9, a signal of deteriorating financial health, and negative return on equity of -6.6% (sector average: -20.6%), and minimal leverage with a debt-to-equity ratio of 0.00.
StockPik's composite Value Score for AEHR is 22/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.
AEHR reports a moderate gross margin of 34.0% (sector average: 40.1%) and a negative operating margin of -28.4%.
AEHR shows revenue declining at 11% year-over-year, with earnings declining at 112%.